[HTML][HTML] Machine learning approaches to genome-wide association studies

DO Enoma, J Bishung, T Abiodun, O Ogunlana… - Journal of King Saud …, 2022‏ - Elsevier
Abstract Genome-wide Association Studies (GWAS) are conducted to identify single
nucleotide polymorphisms (variants) associated with a phenotype within a specific …

Pharmacogenetic panel testing: a review of current practice and potential for clinical implementation

R Mosch, M van der Lee, HJ Guchelaar… - Annual Review of …, 2025‏ - annualreviews.org
Pharmacogenetics (PGx) aims to optimize drug treatment outcomes by using a patient's
genetic profile for individualized drug and dose selection. Currently, reactive and …

AI can help to tailor drugs for Africa—but Africans should lead the way

G Turon, M Njoroge, M Mulubwa, M Duran-Frigola… - Nature, 2024‏ - nature.com
Computational models that require very little data could transform biomedical and drug
development research in Africa, as long as infrastructure, trained staff and secure databases …

Environmental toxicology in addressing public health challenges in Africa

W Ndudi, GI Edo, AN Jikah, K Zainulabdeen… - Ecological Frontiers, 2024‏ - Elsevier
Environmental toxicology is a diverse scientific discipline that is highly influential in the field
of toxicology, environmental health, and public policy. However, there is a paucity of data …

Advancing pharmacogenetics research in Africa: the “Project Africa GRADIENT” initiative

CAAN Sima, H Othman, M Möller… - Drug discovery today, 2024‏ - Elsevier
Africa is home to some of the most genetically diverse populations in the world, with a
population of over 1.2 billion people comprised of over 3,000 distinct ethnic groups and a …

The extent and impact of variation in ADME genes in sub-Saharan African populations

JEB Da Rocha, H Othman, G Botha, L Cottino… - Frontiers in …, 2021‏ - frontiersin.org
Introduction: Investigating variation in genes involved in the absorption, distribution,
metabolism, and excretion (ADME) of drugs are key to characterizing pharmacogenomic …

From drug discovery to drug approval: a comprehensive review of the pharmacogenomics status quo with a special focus on Egypt

FM Elgarhy, A Borham, N Alziny, KR AbdElaal… - …, 2024‏ - pmc.ncbi.nlm.nih.gov
Pharmacogenomics (PGx) is the hope for the full optimization of drug therapy while
minimizing the accompanying adverse drug events that cost billions of dollars annually …

The role of pharmacogenomics studies for precision medicine among Ethiopian patients and their clinical implications: a sco** review

KA Getahun, DA Angaw, MS Asres… - Pharmacogenomics …, 2024‏ - Taylor & Francis
Background Pharmacogenomics research is currently revolutionizing treatment optimization
by discovering molecular markers. Medicines are the cornerstone of treatment for both acute …

[HTML][HTML] Allostery and missense mutations as intermittently linked promising aspects of modern computational drug discovery

ÖT Bishop, TM Musyoka, V Barozi - Journal of Molecular Biology, 2022‏ - Elsevier
Drug research and development is a multidisciplinary field with its own successes. Yet,
given the complexity of the process, it also faces challenges over the long development …

Map** the pharmacogenetic landscape in a Ugandan population: implications for personalized medicine in an underrepresented population

SR Samarasinghe, S Lee, M Corpas… - Clinical …, 2024‏ - Wiley Online Library
Africans are extremely underrepresented in global genomic research. African populations
face high burdens of communicable and non‐communicable diseases and experience …